Back to News
Market Impact: 0.55

British American Tobacco: Still An Undervalued Dividend Machine

BTIMO
Company FundamentalsCorporate EarningsCapital Returns (Dividends / Buybacks)Interest Rates & YieldsRegulation & LegislationAnalyst InsightsCorporate Guidance & Outlook
British American Tobacco: Still An Undervalued Dividend Machine

British American Tobacco (BTI) shares have doubled from their 2024 lows, yet the company is highlighted as still undervalued, trading below 12x 2025 earnings with a substantial 5.79% dividend yield. The company reported year-over-year revenue and profitability growth in Q2 2025, driven by price increases and expansion in smokeless products, which now constitute 18.2% of revenue. BTI projects over $58 billion in free cash flow from 2024-2030, underpinning its dividend and potential buybacks, presenting a compelling value and income opportunity, especially as potential rate cuts enhance its yield's attractiveness.

Analysis

British American Tobacco (BTI) presents a compelling value and income case, even after its share price doubled from 2024 lows. The company trades at an attractive forward valuation of under 12 times 2025 projected earnings, supported by a significant 5.79% dividend yield. Q2 2025 results demonstrated year-over-year growth in both revenue and profitability, driven by a combination of traditional price increases and successful expansion in its smokeless product category, which now constitutes a material 18.2% of total revenue. The company's strategic guidance reinforces this positive outlook, projecting over $58 billion in free cash flow generation from 2024 to 2030. This robust cash flow is earmarked to support the dividend, fund share buybacks, and facilitate deleveraging. While the investment thesis is subject to the industry's inherent regulatory and health-related risks, BTI's high yield becomes increasingly attractive in a macroeconomic environment characterized by potential interest rate cuts.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo